Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT03117257 2017-04-17

Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN

Phase 2 Unknown

144 enrolled

Head & Neck

Head and Neck Neoplasms

NCT02630264 2015-12-15

E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck

Phase 3 Unknown

540 enrolled

Head & Neck

Head and Neck Neoplasms

NCT01372111 2015-12-09

Chemoradiotherapy With Elective Low Dose Nodal Radiation for Locally Advanced Head and Neck Cancer

Phase 2 Unknown

76 enrolled

Head & Neck

Head and Neck Neoplasms

NCT02429037 2015-04-29

P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer

Phase 2 Unknown

60 enrolled

Head & Neck

Head and Neck Neoplasms

NCT02283489 2014-11-05

Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors

Phase 2 Unknown

180 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00003637 2013-12-19

Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx

Phase 3 Unknown

200 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00003182 2013-12-04

Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck

Phase 1/2 Unknown

40 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Salivary Gland Neoplasms

NCT00003251 2013-12-04

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Phase 1/2 Unknown

46 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00002747 2013-09-20

Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer

Phase 3 Unknown

240 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00093665 2013-05-15

Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer

Phase 2 Unknown

90 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00982436 2012-03-22

Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer

Phase 1/2 Unknown

37 enrolled

Head & Neck

Head and Neck Neoplasms

NCT01472653 2011-12-13

Treatment Selection According to Skin Reaction to Cetuximab

Phase 2 Unknown

120 enrolled

Head & Neck

Head and Neck Neoplasms

NCT01301248 2011-05-17

Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck

Phase 2 Unknown

80 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01291095 2011-03-04

Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma

Phase 2 Unknown

80 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00625937 2011-02-28

Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase 2 Unknown

46 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT00634595 2010-07-28

Trial of E10A in Head and Neck Cancer

Phase 2 Unknown

116 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms

NCT00004164 2009-02-09

Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx

Phase 2 Unknown

Head & Neck

Head and Neck Neoplasms, Nasopharyngeal Neoplasms

Clinical Trials

V-CHANCE

Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer

QUASAR

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC

Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer

Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma

DAHANCA 37. Re-irradiation With Proton Radiotherapy

Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) for Recurrent Head and Neck Cancer

A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer

COTI2-101

Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN

E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck

Chemoradiotherapy With Elective Low Dose Nodal Radiation for Locally Advanced Head and Neck Cancer

P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer

Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors

Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx

Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer

Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer

Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer

Treatment Selection According to Skin Reaction to Cetuximab

Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck

Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma

Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Trial of E10A in Head and Neck Cancer

Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx